Home
Conditions
Carcinoma

Clinical trial condition

Carcinoma

Explore clinical trials studying Carcinoma. Study availability and eligibility vary by location and protocol.

8,847 public trials 2,102 recruiting studies

Refine in advanced search Browse all conditions

Carcinoma trial results

Enrolling by invitation

Gem+Nab-P+LEN+TIS for Advanced Unresectable BTC (GALENT-BT)

NCT06963060

Conditions: Adenocarcinoma, Biliary Tract Diseases, Biliary Tract Neoplasms, +11 more
Locations: Xinhua Hospital, Shanghai Jiao Tong University School of Medicine Shanghai, Shanghai Municipality, China

View Trial Details

Enrolling by invitation

Evaluation of [18F]AlF-NOTA-PCP2 PET/CT for PD-L1 Detection in Malignant Tumors

NCT06690216

Conditions: Astrocytoma, Bronchial Neoplasms, Carcinoma, +30 more
Locations: Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences Jinan, Shandong, China

View Trial Details

Enrolling by invitation

Camrelizumab and Chemotherapy With or Without Anlotinib as First-line Treatment for Advanced Gallbladder Cancer and Extrahepatic Cholangiocarcinoma

NCT06901622

Conditions: Adenocarcinoma, Biliary Tract Diseases, Biliary Tract Neoplasms, +11 more
Locations: The First Affiliated Hospital of Zhengzhou University Zhengzhou, China

View Trial Details

Enrolling by invitation

ProA Study: ProActive Management Model in Metastatic Hormone Sensitive Prostate Cancer (mHSPC) Treated by Apalutamide

NCT06865547

Conditions: Adenocarcinoma, Carcinoma, Genital Diseases, +12 more
Locations: Affiliated Cancer Hospital of Sun Yat-sen University Guangzhou, Guangdong, China

View Trial Details

Enrolling by invitation

A Multicenter Trial of YSQTG vs. Simulated Agents With Neoadjuvant Chemoradiotherapy or Chemoimmunotherapy for EC

NCT06863831

Conditions: Carcinoma, Carcinoma, Squamous Cell, Digestive System Diseases, +13 more
Locations: Cancer Hospital, Chinese Academy of Medical Sciences/Peking Union Medical College Beijing, Chaoyang, China

View Trial Details

Enrolling by invitation

PET-TC in Thyroid Evaluation

NCT06852144

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Medullary, +18 more
Locations: Nuclear medicine, IRCCS, Azienda Ospedalierio-Universitaria di Bologna Bologna, Bo, Italy

View Trial Details

Enrolling by invitation

The Adoptive Immunotherapy for Solid Tumors Using Modified Autologous CIK Cells

NCT01868490

Conditions: Adenocarcinoma, Carcinoma, Cholangiocarcinoma, +10 more
Locations: Siriraj Clinical Research Center, Siriraj Hospital Bangkoknoi, Bangkok, Thailand

Faculty of Medicine Siriraj Hospital, Mahidol University Bangkok, Thailand

View Trial Details

Enrolling by invitation

Prognostic Value of TIL in Nasopharyngeal Carcinoma

NCT06763640

Conditions: Carcinoma, Head and Neck Neoplasms, Nasopharyngeal Carcinoma, +12 more
Locations: Jiangxi Cancer Hospital Nanchang, Jiangxi, China

View Trial Details

Enrolling by invitation

Plasma Exosomes Reveal the Efficacy of Targeted Therapy in Patients With EGFR Mutation in Lung Adenocarcinoma

NCT06730477

Conditions: Adenocarcinoma, Adenocarcinoma of Lung, Carcinoma, +9 more
Locations: Union hospital, Tongji Medical college, Huazhong University of Science and Technology Wuhan, Hubei, China

View Trial Details

Enrolling by invitation

Observational Study for SIR-Spheres Therapy for the Treatment of HCC Patients in China

NCT06712017

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +10 more
Locations: The Second Affiliated Hospital of Guangzhou Medical University Guangzhou, Guangdong, China

The First Affiliated Hospital of Jinan University Jinan, Guangdong, China

Xi'An International Medical Center Hospital Xi’an, Guangxi, China

No.1 Affiliated Hospital of Xian Jiaotong University Xi’an, Shanxi, China

View Trial Details

Carcinoma

Carcinoma trial results

Related conditions